Results 201 to 210 of about 77,587 (260)

BTK-Inhibitor Loaded Polymeric Nanoparticles Alleviate Systemic Lupus Erythematosus by Targeting Elimination of Autoreactive BAFFR^high B Cells. [PDF]

Int J Mol Sci
Zhang Y, Wen J, Jiang B, Jiang H, Xu J, Tao J.   +5 more
europepmc   +1 more source

miR-7213-5p-mediated suppression of CCL19 in fibroblast cells may attenuate lupus nephritis. [PDF]

Clin Exp Med
Gao Z, Wang J, Luo L, Zhou L, Qin Y, Zheng K, Li X.   +6 more
europepmc   +1 more source

Epidemiology of Antimicrobial Residues and Phenotypic Resistance of Bacterial Isolates from Waste Milk on California Dairies. [PDF]

Microorganisms
Mihreteab Y, Okello E, Pandey P, Abdelfattah E, Ekong PS, Sheedy D, ElAshmawy WR, Karle BM, Black RA, Williams DR, Aly SS.   +10 more
europepmc   +1 more source

A systematic review of molecular representation learning foundation models. [PDF]

Brief Bioinform
Song B, Zhang J, Liu Y, Liu Y, Jiang J, Yuan S, Zhen X, Liu Y.   +7 more
europepmc   +1 more source

[New animal models for autoimmune diseases; BXSB, MRL/l, MRL/n mice].

Jikken dobutsu. Experimental animals, 1981
openaire   +1 more source

Linear regression in ecological studies involving space: methodology and an application example in public health. [PDF]

Rev Bras Epidemiol
Conceição GMS, Bermudi PMM, Palasio RGS, Barbosa GL, Fernandes CM, Santana LMR, Barrozo LV, Roza DLD, Quintanilha JA, Chiaravalloti-Neto F.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Voluntary consumption of cyclophosphamide by nondeprived Mrl-lpr/lpr and Mrl +/+ mice

Pharmacology Biochemistry and Behavior, 1990
Cyclophosphamide dissolved in several dilutions of chocolate milk was presented for 20 hr daily to nondeprived, symptomatic, autoimmune Mrl-lpr/lpr and asymptomatic Mrl +/+ mice. In the absence of cyclophosphamide, daily consumption was inversely related to the concentration of the chocolate milk solutions and increased from the first to the fourth day
L J, Grota, R, Ader, J A, Moynihan, N, Cohen   +3 more
openaire   +2 more sources

MRI-Linear Accelerator (MRL)

2021
MRI-Linac is a new device that combines an MRI unit and a 6 MV linear accelerator (on a single circular gantry) very similar to a tomotherapy unit for image-guided and adaptive therapy. It uses MRI for planning and image guidance. This device is most useful for treating soft tissue tumors such as liver, pancreas, kidney, and so on.
David S. Chang, Foster D. Lasley, Indra J. Das, Marc S. Mendonca, Joseph R. Dynlacht   +4 more
openaire   +1 more source